Skip to content
Oric PharmaceuticalsInc

Viking Global Investors Oric PharmaceuticalsInc transactions over time

ORIC

Oric PharmaceuticalsInc historical holders

total: 1

Transactions details

Total transactions:
7
New positions:
1
Added:
2
Reduced:
4
Held for:
0 quarters
Latest activity:
2026 Q3
Ole Andreas Halvorsen has been an institutional investor in Oric PharmaceuticalsInc (ORIC) since 2024 Q1. According to 2026 Q3 report, Ole Andreas Halvorsen holds 3,562,915 shares with a market value of roughly $47.99M representing 0.15% of their equity portfolio. The fund/company first acquired ORIC in 2024 Q1, initially purchasing about 4.00M shares. Since the initial investment, Viking Global Investors has made 6 more transactions in this position.

Does Ole Andreas Halvorsen still hold ORIC?

Yes, Ole Andreas Halvorsen continues to hold Oric PharmaceuticalsInc (ORIC). According to their 2026 Q3 report, they maintain a position of 3,562,915 shares valued at approximately $47.99M, representing 0.15% of their equity portfolio.

When did Ole Andreas Halvorsen first invest in ORIC?

Ole Andreas Halvorsen first invested in Oric PharmaceuticalsInc (ORIC) in 2024 Q1 at the reported quarter-end price of $13.75 per share, acquiring 4,000,000 shares in their initial purchase.

ORIC transactions history by Viking Global Investors

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
0.15%
3,562,915
$13.47
$47,992,465
-30.50% (-1,563,847)
-0.06%
2026 Q2
0.16%
5,126,762
$10.83
$55,522,832
-11.98% (-697,771)
-0.02%
2026 Q1
0.21%
5,824,533
$12.67
$73,796,833
-11.38% (-748,158)
-0.03%
2025 Q4
0.14%
6,572,691
$8.18
$53,764,612
-0.00% (-9)
0%
2025 Q1
0.12%
6,572,700
$5.58
$36,675,666
+48.33% (+2,141,692)
+0.04%
2024 Q4
0.12%
4,431,008
$8.07
$35,758,235
+10.78% (+431,008)
+0.01%
2024 Q1
0.20%
4,000,000
$13.75
$55,000,000
new
+0.2%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.